Clinical Trial Update: A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03. [Phase 2]

View source ↗

Summary

Phase 2 study evaluating TTAX03 versus saline for mild to moderate dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Dry Eye Disease with Severe Keratitis

Drugs mentioned

• TTAX03

Snippet

Sponsor: BioTissue Holdings, Inc | Conditions: Dry Eye, Dry Eye Disease (DED) | Phase 2 | Status: COMPLETED